Clinical Trial Participants needed!

A Randomized Placebo control trial led by Dr. Luis Nacul at BC Women’s Hospital is seeking participants with Long-COVID. The trial is looking for patients with profound and persistent fatigue along with other symptoms (brain fog, sleep problems, etc.). The purpose of the trial is to investigate the use of low-dose naltrexone (LDN) as a possible treatment for post-COVID-19 fatigue syndrome (PCFS), and determine if LDN reduces fatigue and pain, and improves symptoms associated with PCFS. The trial is called A Double Blind Randomized Trial of Low-Dose Naltrexone for Post-COVID Fatigue Syndrome (LDN Trial).

The study will take place over 16 weeks and the main study tasks will involve the following: 

• Taking LDN or a placebo (an inactive substance) for 16 weeks

• Virtual or in-person study visits and check-ins with the study team

• Completion of questionnaires 

• Wearing a pedometer (step counter) for one week, twice during the trial period

• Collecting blood samples

Interested individuals may be eligible for participation if they:

• Are between the ages 19 to 69 years old

• Are a resident of British Columbia, Canada

• Had COVID-19 at least three months ago, as confirmed by a physician or positive test result

• Meet the clinical diagnostic criteria for PCFS (this will be confirmed by a physician)  

• Agree to maintain any other regular medications at their current doses for the duration of the trial

If you fit these criteria and are interested in participating, please sign up for REACH BC and indicate your interest on the study page.

Thank you!

Caution: if you like, comment or follow this post, you may be publicly identified with the study.